UK's Oxford Nanopore gains as CEO reportedly flags takeover exposure
** Biotech group Oxford Nanopore Technologies ONT.L up as much as 5.7% at 115.9p ** Gene sequencing specialist is now "exposed" to acquisition, CEO and co-founder Gordon Sanghera told FT ** ONT's shares have lost 85% since its peak in 2021 ** "Bankers have said it could be attractive to one of the big diagnostics specialists, such as Thermo Fisher Scientific TMO.N or Danaher DHR.N," FT report adds ** As of last close, stock down ~15% this year (Reporting by Radhika Anilkumar in Bengaluru) ((Radhika.Anilkumar@thomsonreuters.com;))
Recent news on Oxford Nanopore Technologies
See all newsBrief: Oxford Nanopore Technologies Says Nick Keher, CFO, To Assume Additional Responsibilities From July 1, 2026
Oxford Nanopore Tech - Changes to Director Roles and Responsibilities
UK's IP Group rebuffs top investor Railpen's $810 million takeover proposal
Brief: Railways Pension Trustee Company Limited Announces Possible Offer For All IP Group Shares
Oxford Nanopore Tech - Share Incentive Plan - Director/PDMR Shareholding